Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Weight loss jab ‘may carry higher risk of sudden sight loss’ as new warning issued - Wegovy is approved on the NHS to help people lose weight in higher doses ...

EXCLUSIVE: Americans who suffered devastating side effects after taking GLP-1 drugs Ozempic and Wegovy tell Rhian Lubin why they are suing. “If someone would have told me ... a drug I was taking could ...

Semaglutide, in any formulation, was the only agent significantly associated with eye stroke, with the strongest signal for Wegovy, followed by Ozempic. Men were found to be 3 times more at risk than ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug ...

Semaglutide brands Wegovy, Ozempic and Rybelsus – made by Novo Nordisk – all have the same active ingredient, but differ in ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation ...